RPS Pharmacy Research Journals
@rpsresearch.bsky.social
Dedicated to advancing pharmaceutical sciences, pharmacy practice and health services research
Altmetric scores as well as originality, potential impact and significance as assessed by the Editor-in-Chief.
If you would like to be in with a chance of winning, then submit your next piece of #Pharmacology or #Pharmaceutics research to #JPP!
If you would like to be in with a chance of winning, then submit your next piece of #Pharmacology or #Pharmaceutics research to #JPP!
November 6, 2025 at 6:14 PM
Altmetric scores as well as originality, potential impact and significance as assessed by the Editor-in-Chief.
If you would like to be in with a chance of winning, then submit your next piece of #Pharmacology or #Pharmaceutics research to #JPP!
If you would like to be in with a chance of winning, then submit your next piece of #Pharmacology or #Pharmaceutics research to #JPP!
The JPP Paper of the Year recognises the most significant paper published in the journal in the previous year based on quantitative measures such as citations, article downloads and
November 6, 2025 at 6:14 PM
The JPP Paper of the Year recognises the most significant paper published in the journal in the previous year based on quantitative measures such as citations, article downloads and
We are delighted to announce that the above papers have been chosen as the joint winners of the JPP Paper of the Year Award 2024!
November 6, 2025 at 6:13 PM
We are delighted to announce that the above papers have been chosen as the joint winners of the JPP Paper of the Year Award 2024!
➡️ Stephen Doherty, Paul Forsyth, Petra Rauchhaus, Christine Bond, Susan Roberts FRPharmS, Jane Brown, Laura O'Loan, Fiona Marra, Joseph Oakley, Michele Sehrawat, Debra Roberts, Andrew Radley
October 23, 2025 at 1:47 PM
➡️ Stephen Doherty, Paul Forsyth, Petra Rauchhaus, Christine Bond, Susan Roberts FRPharmS, Jane Brown, Laura O'Loan, Fiona Marra, Joseph Oakley, Michele Sehrawat, Debra Roberts, Andrew Radley
This special issue collates the latest research on the challenges faced by global pharmaceutical and health supply systems with regards to #transparency, #accountablity, good #governance practices and #trustworthiness.
October 17, 2025 at 3:52 PM
This special issue collates the latest research on the challenges faced by global pharmaceutical and health supply systems with regards to #transparency, #accountablity, good #governance practices and #trustworthiness.
➡️ Screening adsorbents for the prevention of drug-induced intestinal dysbiosis at pre-formulation stage: case example activated charcoal
➡️ Lea Gnatzy, Dimitris-Marios Katsikis, Konstatinos Papaandreou, George Ismailos, Maria Vertzoni, Christos Reppas
➡️ Lea Gnatzy, Dimitris-Marios Katsikis, Konstatinos Papaandreou, George Ismailos, Maria Vertzoni, Christos Reppas
September 24, 2025 at 1:23 PM
➡️ Screening adsorbents for the prevention of drug-induced intestinal dysbiosis at pre-formulation stage: case example activated charcoal
➡️ Lea Gnatzy, Dimitris-Marios Katsikis, Konstatinos Papaandreou, George Ismailos, Maria Vertzoni, Christos Reppas
➡️ Lea Gnatzy, Dimitris-Marios Katsikis, Konstatinos Papaandreou, George Ismailos, Maria Vertzoni, Christos Reppas
"A 2024 review in the Journal of Pharmaceutical Health Services Research reveals that while 100% of pharmaceutical social media posts highlight drug benefits, only 33% mention potential harms."
September 23, 2025 at 11:05 AM
"A 2024 review in the Journal of Pharmaceutical Health Services Research reveals that while 100% of pharmaceutical social media posts highlight drug benefits, only 33% mention potential harms."
Read the FDA press release here: 🔗https://www.fda.gov/news-events/press-announcements/fda-launches-crackdown-deceptive-drug-advertising
September 23, 2025 at 11:05 AM
Read the FDA press release here: 🔗https://www.fda.gov/news-events/press-announcements/fda-launches-crackdown-deceptive-drug-advertising
"About half of the medication lists of older patients were assessed as requiring pharmacist action before the drugs could be safely dispensed, drug interaction alerts being the most frequent underlying reason.."
September 17, 2025 at 12:50 PM
"About half of the medication lists of older patients were assessed as requiring pharmacist action before the drugs could be safely dispensed, drug interaction alerts being the most frequent underlying reason.."
The results of this study have direct implications for policymakers and state legislators by providing real-world evidence surrounding the viability of medical marijuana policy implementations."
September 16, 2025 at 9:40 AM
The results of this study have direct implications for policymakers and state legislators by providing real-world evidence surrounding the viability of medical marijuana policy implementations."